Business | Monday August 12, 2013
Sun Pharma, which had reported earnings after markets closed on Friday, attributed losses due to a provision for settling a patent suit. Sun Pharma, along with Teva Pharmaceuticals, has to pay Pfizer Inc $2.15 billion to settle a patent suit related to marketing generic versions of its acid-reflux drug Protonix.
www.ndtv.com/business